1313892-07-7

Basic information

• Product Name: C₂₂H₁₅FN₆OS*ClH
• CAS NO: 1313892-07-7
• Molecular Weight: 466.926
• Mol File: 1313892-07-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₂₂H₁₅FN₆OS*ClH(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₂H₁₅FN₆OS*ClH(1313892-07-7)
• EPA Substance Registry System: C₂₂H₁₅FN₆OS*ClH(1313892-07-7)

Safety Data

• Hazardous Substances Data: 1313892-07-7(Hazardous Substances Data)

Upstream product

• 1882-69-5 5-methoxy-2-nitro-benzoic acid 
• 6705-03-9 2-Amino-5-methoxybenzoic acid 
• 32618-84-1 6-Methoxyquinazolin-2,4-dione 
• 105763-77-7 2,4-dichloro-6-methoxy-quinazoline 

Relevant articles and documents

The therapeutic compound, use and related method (by machine translation)

PROBLEM TO BE SOLVED: To provide a pharmaceutical composition containing a compound or its salt which prevents or treats a central nervous system disease in which integration dysfunction syndrome and agnosia are enumerated as exemplary disorders.SOLUTION: The pharmaceutical composition includes the compound or its salt represented by chemical formula (A) which modulates striatal-enriched protein tyrosine phosphatase (STEP).